53, 95% confidence interval (CI)&nbsp;-2.44 to&nbsp;-0.61], incremental glucose response (SMD&nbsp;-1.19, 95% CI&nbsp;-1.71 to&nbsp;-0.68), area under the curve of plasma insulin (SMD&nbsp;-0.65, 95% CI&nbsp;-1.03 to&nbsp;-0.26), mean blood glucose level (SMD&nbsp;-0.41, 95% CI&nbsp;-0.63 to&nbsp;-0.19), glycosylated haemoglobin (HbA1c) change (SMD&nbsp;-0.63, 95% CI&nbsp;-1.21 to&nbsp;-0.05), glucose variability (SMD&nbsp;-0.93,&nbsp;-1.55 to&nbsp;-0.31), mean administered insulin dose (SMD&nbsp;-0.49, 95% CI&nbsp;-0.85 to&nbsp;-0.14), mean blood triglycerides (SMD&nbsp;-0.34, 95% CI&nbsp;-0.65 to&nbsp;-0.03) and increase of mean blood high-density lipoproteins (SMD&nbsp;+0.42, 95% CI 0.08 to 0.76). Non-significant differences were found for tolerance [odds ratio (OR) 0.95, 95% CI 0.87 to 1.05]. CONCLUSIONS This meta-analysis shows that a DSF (oral supplements and tube feeds) high in MUFAs can improve glucose control and metabolic risk factors among patients with diabetes or stress-induced hyperglycaemia compared with a STDF. Cellulose nanocrystals (CNCs) have received a significant amount of attention from the researchers. It is used as a nanomaterial for various applications due to its excellent physiochemical properties for the last few decades. Self-assembly is a phenomenon where autonomous reorganization of randomly oriented species occurs elegantly. Self-assembly is responsible for the formation of the hierarchical cholesteric structure of CNCs. This process is highly influenced by several factors, such as the surface chemistry of the nanoparticles, intermolecular forces, and the fundamental laws of thermodynamics. Various conventional experimental designs and molecular dynamics (MD) studies have been applied to determine the possible mechanism of self-assembly in CNCs. Different external factors, like pH, temperature, magnetic/electric fields, vacuum, also influence the self-assembly process in CNCs. Notably, better responses have been observed in CNCs-grafted polymer nanocomposites. These functionalized CNCs with stimuli-responsive self-assembly have immense practical applications in modern biotechnology and medicine. Herein, we have concisely discussed the mechanism of the self-assembled CNCs in the presence of different external factors such as pH, temperature, electric/magnetic fields, and their biomedical applications. A special flower-like chitosan (CS)/calcium phosphate (CaP) microparticle was fabricated as a novel pH-sensitive carrier for sustained release drug system via a rapid one-pot approach. The CS-tripolyphosphate (TPP) nanocomplexes were firstly prepared through ionotropic gelation. Then, the CS nanocomplexes network acted as the template and inducer for adsorbing the mineralized CaP nanosheets and directing its assembly into the flower-like microparticles. The preparation condition optimized by Box-Behnken design-response surface methodology was achieved with 3.16&nbsp;mg/ml of CS, 127.22&nbsp;mg/ml of TPP, and 89.50&nbsp;mM of CaCl2. The morphologies of the system were observed by scanning electron microscopy (SEM) and transmission electron microscope (TEM), and it showed that the flower-like microparticles with a diameter of 5-7&nbsp;μm are composed of sheet-like petals with about 40&nbsp;nm in thickness. And the TEM results showed that the petals consist by nanosheets with the thickness of 2-5&nbsp;nm. The X-ray diffraction (XRD) results showed that the P/Ca ratio of CS/CaP microparticles is 1.29/1. The in vitro release studies demonstrated well sustained-release properties and pH-sensitive releasing characteristic of CS/CaP microparticles. The drug release mechanism was fitted by Korsmeyer-Peppas model at a pH of 5.8 and 7.4, respectively. The in vitro cell viability research demonstrated the microparticles have no obvious cytotoxicity at the dosages below 500&nbsp;μg/ml. This work supplied a versatile platform as a novel drug delivery system with excellent pH-sensitive and sustained release performances. Glial cells can mediate hypothalamic inflammatory processes induced in response to a high-fat diet (HFD). https://www.selleckchem.com/GSK-3.html We used magnetic-activated cell sorting (MACS) to isolate microglia and astrocytes from hypothalamus of mice fed HFD and examined changes in expression of inflammation-related cytokines and markers related to glial cell activation status. Hypothalamus from male C57BL6 mice fed a chow diet (chow) or HFD for 1, 3, or 28 days were collected and microglia and astrocytes were isolated by MACS. After confirming cell viability by fluorescence activated cell sorting, mRNA expression levels of inflammation-related cytokines and markers of glial cell activation status were examined by qRT-PCR, which revealed that both glial cell types isolated by MACS retained specificity. On day 3 of HFD, both CD86 and TNFα mRNA expression was significantly increased in microglia relative to the chow group. In astrocytes, TNFα mRNA expression levels were similar between the chow and HFD groups on day 3, but anti-inflammatory cytokine IL-10 levels were significantly increased. On day 7 of HFD, TNFα expression in microglia decreased to levels comparable to the chow group while that in astrocytes remained unchanged. On day 28 of HFD, TNFα levels were significantly increased in both microglia and astrocytes, which had increased mRNA expression of CD86 and MAO-B, respectively. For both glial cell types, results for TNFα expression assessed by RT-PCR and immunohistochemical analysis were similar. These results indicate that the role of microglia and astrocytes in hypothalamic inflammation under HFD conditions changed with time and these changes were accompanied by changes in the activation status of glial cells. Our data suggest that early after initiating HFD, hypothalamic astrocytes suppress diet-induced inflammation at least in part by secreting IL-10, whereas continued HFD feeding impairs this suppressive function such that both microglia and astrocytes promote hypothalamic inflammation. Despite the focus placed on cardiovascular research, the prevalence of vascular and valvular calcification is increasing and remains a leading contributor of cardiovascular morbidity and mortality. Accumulating studies provide evidence that cardiovascular calcification is an inflammatory disease in which innate immune signaling becomes sustained and/or excessive, shaping a deleterious adaptive response. The triggering immune factors and subsequent inflammatory events surrounding cardiovascular calcification remain poorly understood, despite sustained significant research interest and support in the field. Most studies on cardiovascular calcification focus on innate cells, particularly macrophages' ability to release pro-osteogenic cytokines and calcification-prone extracellular vesicles and apoptotic bodies. Even though substantial evidence demonstrates that macrophages are key components in triggering cardiovascular calcification, the crosstalk between innate and adaptive immune cell components has not been adequately addressed.